bladder cancer

Showing NaN - NaN of 74

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bladder Cancer Trial in Houston (Bladder tumor biopsy)

Recruiting
  • Bladder Cancer
  • Bladder tumor biopsy
  • Houston, Texas
    Baylor College of Medicine
Jan 14, 2022

Bladder Cancer Trial in United States (Gemcitabine, Cisplatin, Methotrexate)

Active, not recruiting
  • Bladder Cancer
  • Birmingham, Alabama
  • +565 more
Dec 3, 2021

Ovary Cancer, Cervix Cancer, Endometrium Cancer Trial in Worldwide (Tisotumab Vedotin (HuMax-TF-ADC))

Completed
  • Ovary Cancer
  • +7 more
  • Tisotumab Vedotin (HuMax-TF-ADC)
  • Orange, California
  • +28 more
Nov 29, 2021

Lung Cancer, Breast Cancer, Colon Cancer Trial in Houston, White River Junction (SAFER TRACKS Intervention)

Active, not recruiting
  • Lung Cancer
  • +4 more
  • SAFER TRACKS Intervention
  • Houston, Texas
  • +1 more
Nov 2, 2021

Bladder Cancer Trial in United States (Hexaminolevulinate HCl (HCL), Karl Storz D-Light C Photodynamic Diagnostic (PDD) system)

Recruiting
  • Bladder Cancer
  • Hexaminolevulinate hydrochloride (HCL)
  • Karl Storz D-Light C Photodynamic Diagnostic (PDD) system
  • Los Angeles, California
  • +12 more
Oct 15, 2021

Oncology, Breast Cancer, Prostate Cancer Trial in Worldwide (Radiation therapy)

Recruiting
  • Oncology
  • +37 more
  • Radiation therapy
  • Houston, Texas
  • +7 more
Aug 23, 2021

High Resolution Imaging for Early and Better Detection of

Completed
  • Bladder Cancer
  • Standard High Resolution Microendoscope and/or Line-Scanning Confocal High Resolution Microendoscope
  • Houston, Texas
    Lyndon B. Johnson General Hospital
Jun 22, 2021

Bladder Cancer Trial in Canada, United States (Vicinium)

Active, not recruiting
  • Bladder Cancer
  • Vicinium
  • Birmingham, Alabama
  • +69 more
Jun 10, 2021

Bladder Cancer, Urethral Cancer, Urachal Cancer Trial in Houston (5-Fluorouracil (5-FU), Leucovorin, Cisplatin)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • 5-Fluorouracil (5-FU)
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 18, 2021

Ovary Cancer, Cervix Cancer, Endometrium Cancer Trial in Worldwide (Tisotumab vedotin (HuMax-TF-ADC))

Completed
  • Ovary Cancer
  • +6 more
  • Tisotumab vedotin (HuMax-TF-ADC)
  • Houston, Texas
  • +15 more
Mar 15, 2021

Bladder Cancer Trial in Houston (Tamoxifen Citrate)

Completed
  • Bladder Cancer
  • Tamoxifen Citrate
  • Houston, Texas
  • +1 more
Dec 18, 2020

Bladder Cancer Trial in United States (Post-Operative Recovery Registry)

Recruiting
  • Bladder Cancer
  • Post-Operative Recovery Registry
  • San Francisco, California
  • +10 more
Dec 1, 2020

Bladder Cancer Trial in Canada, United States (drug, procedure, radiation)

Completed
  • Bladder Cancer
  • Birmingham, Alabama
  • +228 more
Oct 19, 2020

Screening for Bladder Cancer

Completed
  • Bladder Cancer
  • Specimen and questionnaires only
  • Rochester, New York
  • +2 more
Feb 21, 2020

Bladder Cancer Trial in United States (HS-410, Placebo, BCG)

Terminated
  • Bladder Cancer
  • HS-410
  • +2 more
  • Los Angeles, California
  • +18 more
Feb 13, 2020

Colorectal Cancer, Triple Negative Breast Cancer, Pancreatic Cancer Trial in Denver, Miami, Houston (Toca 511, Toca FC)

Terminated
  • Colorectal Cancer
  • +11 more
  • Toca 511
  • Toca FC
  • Denver, Colorado
  • +2 more
Feb 5, 2020

Bladder Cancer Trial in United States (gemcitabine HCl, )

Completed
  • Bladder Cancer
  • gemcitabine hydrochloride
  • placebo
  • Little Rock, Arkansas
  • +69 more
Jan 8, 2020

The Molecular Predisposition to Hereditary Nonpolyposis Colon

Unknown status
  • Bladder Cancer
  • +5 more
  • Health and Diet Questionnaire
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 5, 2020

Genetic Susceptibility to Bladder Cancer

Recruiting
  • Bladder Cancer
  • Interviews
  • Houston, Texas
  • +1 more
Oct 24, 2019

Improving Clinical Staging for Muscle Invasive Bladder Cancer

Completed
  • Bladder Cancer
  • Tissue Biopsy
  • Magnetic Resonance Imaging (MRI)
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 20, 2019

Longer-term Recurrence Rates in Bladder Cancer After

Completed
  • Bladder Cancer
    • Stanford, California
    • +23 more
    Mar 28, 2019

    Urinary Sediment in Detecting Bladder Cancer

    Completed
    • Bladder Cancer
    • loss of heterozygosity analysis
    • +6 more
    • Birmingham, Alabama
    • +12 more
    Feb 6, 2019

    Bladder Cancer Trial in Houston, Seattle (Fenretinide, Placebo)

    Completed
    • Bladder Cancer
    • Houston, Texas
    • +2 more
    Nov 7, 2018